Fundora Yiliam, Hessheimer Amelia J, Del Prete Luca, Maroni Lorenzo, Lanari Jacopo, Barrios Oriana, Clarysse Mathias, Gastaca Mikel, Barrera Gómez Manuel, Bonadona Agnès, Janek Julius, Boscà Andrea, Álamo Martínez Jose María, Zozaya Gabriel, López Garnica Dolores, Magistri Paolo, León Francisco, Magini Giulia, Patrono Damiano, Ničovský Jiří, Hakeem Abdul Rahman, Nadalin Silvio, McCormack Lucas, Palacios Pilar, Zieniewicz Krzysztof, Blanco Gerardo, Nuño Javier, Pérez Saborido Baltasar, Echeverri Juan, Bynon J Steve, Martins Paulo N, López López Víctor, Dayangac Murat, Lodge J Peter A, Romagnoli Renato, Toso Christian, Santoyo Julio, Di Benedetto Fabrizio, Gómez-Gavara Concepción, Rotellar Fernando, Gómez-Bravo Miguel Ángel, López Andújar Rafael, Girard Edouard, Valdivieso Andrés, Pirenne Jacques, Lladó Laura, Germani Giacomo, Cescon Matteo, Hashimoto Koji, Quintini Cristiano, Cillo Umberto, Polak Wojciech G, Fondevila Constantino
General & Digestive Surgery Service, Hospital Clínic, Barcelona, Spain.
General & Digestive Surgery Service, Hospital Clínic, Barcelona, Spain; General & Digestive Surgery Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
J Hepatol. 2023 Apr;78(4):794-804. doi: 10.1016/j.jhep.2023.01.007. Epub 2023 Jan 21.
BACKGROUND & AIMS: Complex portal vein thrombosis (PVT) is a challenge in liver transplantation (LT). Extra-anatomical approaches to portal revascularization, including renoportal (RPA), left gastric vein (LGA), pericholedochal vein (PCA), and cavoportal (CPA) anastomoses, have been described in case reports and series. The RP4LT Collaborative was created to record cases of alternative portal revascularization performed for complex PVT.
An international, observational web registry was launched in 2020. Cases of complex PVT undergoing first LT performed with RPA, LGA, PCA, or CPA were recorded and updated through 12/2021.
A total of 140 cases were available for analysis: 74 RPA, 18 LGA, 20 PCA, and 28 CPA. Transplants were primarily performed with whole livers (98%) in recipients with median (IQR) age 58 (49-63) years, model for end-stage liver disease score 17 (14-24), and cold ischemia 431 (360-505) minutes. Post-operatively, 49% of recipients developed acute kidney injury, 16% diuretic-responsive ascites, 9% refractory ascites (29% with CPA, p <0.001), and 10% variceal hemorrhage (25% with CPA, p = 0.002). After a median follow-up of 22 (4-67) months, patient and graft 1-/3-/5-year survival rates were 71/67/61% and 69/63/57%, respectively. On multivariate Cox proportional hazards analysis, the only factor significantly and independently associated with all-cause graft loss was non-physiological portal vein reconstruction in which all graft portal inflow arose from recipient systemic circulation (hazard ratio 6.639, 95% CI 2.159-20.422, p = 0.001).
Alternative forms of portal vein anastomosis achieving physiological portal inflow (i.e., at least some recipient splanchnic blood flow reaching transplant graft) offer acceptable post-transplant results in LT candidates with complex PVT. On the contrary, non-physiological portal vein anastomoses fail to resolve portal hypertension and should not be performed.
Complex portal vein thrombosis (PVT) is a challenge in liver transplantation. Results of this international, multicenter analysis may be used to guide clinical decisions in transplant candidates with complex PVT. Extra-anatomical portal vein anastomoses that allow for at least some recipient splanchnic blood flow to the transplant allograft offer acceptable results. On the other hand, anastomoses that deliver only systemic blood flow to the allograft fail to resolve portal hypertension and should not be performed.
复杂门静脉血栓形成(PVT)是肝移植(LT)中的一项挑战。病例报告及系列研究中已描述了门静脉重建的非解剖学方法,包括肾门静脉(RPA)、胃左静脉(LGA)、胆总管周围静脉(PCA)和腔门静脉(CPA)吻合术。成立RP4LT协作组以记录因复杂PVT而进行的替代性门静脉重建病例。
2020年启动了一项国际观察性网络注册研究。记录了通过RPA、LGA、PCA或CPA进行首次LT的复杂PVT病例,并更新至2021年12月。
共有140例病例可供分析:74例RPA、18例LGA、20例PCA和28例CPA。移植主要采用全肝(98%),受者中位(IQR)年龄为58(49 - 63)岁,终末期肝病模型评分17(14 - 24),冷缺血时间431(360 - 505)分钟。术后,49%的受者发生急性肾损伤,16%出现利尿剂反应性腹水,9%出现顽固性腹水(CPA组为29%,p<0.001),10%发生静脉曲张出血(CPA组为25%,p = 0.002)。中位随访22(4 - 67)个月后,患者和移植物1年/3年/5年生存率分别为71%/67%/61%和69%/63%/57%。多因素Cox比例风险分析显示,与全因移植物丢失显著且独立相关的唯一因素是非生理性门静脉重建,即所有移植物门静脉血流均来自受者体循环(风险比6.639,95%CI 2.159 - 20.422,p = 0.001)。
实现生理性门静脉血流(即至少有一些受者内脏血流到达移植移植物)的替代性门静脉吻合形式,在患有复杂PVT的LT候选者中可提供可接受的移植后结果。相反,非生理性门静脉吻合无法解决门静脉高压,不应进行。
复杂门静脉血栓形成(PVT)是肝移植中的一项挑战。这项国际多中心分析的结果可用于指导患有复杂PVT的移植候选者的临床决策。允许至少一些受者内脏血流到达移植同种异体移植物的非解剖学门静脉吻合可提供可接受的结果。另一方面,仅将体循环血流输送至同种异体移植物的吻合无法解决门静脉高压,不应进行。